Who makes IDP-126 Component B?

IDP-126 Component B is developed by Bausch Health Americas, Inc..

What development phase is IDP-126 Component B in?

IDP-126 Component B is in Phase 2.

Last reviewed 2026-04-19 · How we verify

IDP-126 Component B

Bausch Health Americas, Inc. · Phase 2 active Small molecule

At a glance

Generic name	IDP-126 Component B
Sponsor	Bausch Health Americas, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

IDP-126 Component B CI brief — competitive landscape report
IDP-126 Component B updates RSS · CI watch RSS
Bausch Health Americas, Inc. portfolio CI